Nasopharyngeal surfactant administration to prevent neonatal respiratory distress syndrome

J Perinatol. 2005 May;25(5):361-2; author reply 363. doi: 10.1038/sj.jp.7211264.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Cohort Studies
  • Critical Care
  • Female
  • Follow-Up Studies
  • Humans
  • Infant, Low Birth Weight
  • Infant, Newborn
  • Infant, Premature*
  • Intensive Care Units, Neonatal
  • Male
  • Nasopharynx / drug effects*
  • Primary Prevention / methods
  • Pulmonary Surfactants / therapeutic use*
  • Respiratory Distress Syndrome, Newborn / drug therapy
  • Respiratory Distress Syndrome, Newborn / prevention & control*
  • Risk Assessment
  • Survival Rate
  • Treatment Outcome

Substances

  • Pulmonary Surfactants